Stockreport

Inventiva: Biotech To Consider Despite Short NASH Study Enrollment Pause [Seeking Alpha]

Inventiva S.A. - American Depository Shares  (IVA) 
PDF Publication of results from phase IIa LEGEND study, using lanifibranor in combination with Jardiance for the treatment of patients with NASH and Type 2 Diabetes, expect [Read more]